This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2007-2019.
Company Filing History:
Years Active: 2007-2019
Title: Kenta Wada: Innovator in Pharmaceutical Composition
Introduction
Kenta Wada is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid preparations containing tofogliflozin. With a total of 3 patents to his name, Wada's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Wada's latest patents focuses on solid preparations containing tofogliflozin and the process of producing the same. This invention provides a method for producing a pharmaceutical composition in tablet form, which includes tofogliflozin as an active ingredient. The method involves mixing an additive with tofogliflozin to create a powder mixture, which is then compressed to form a tablet. The additive used in this process comprises at least one filler, enhancing the tablet's formulation.
Career Highlights
Kenta Wada is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His work at Chugai has allowed him to focus on innovative solutions that address the needs of patients and healthcare providers alike. Wada's dedication to research and development has positioned him as a key player in his field.
Collaborations
Wada has collaborated with several talented individuals, including Kenichi Sakai and Tomoaki Hirayama. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work.
Conclusion
Kenta Wada's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in the field.
